Loading organizations...
§ Private Profile · Menlo Park, CA, USA
Synthetic biology company producing KSMs and APIs for essential medicines using advanced biosynthesis in engineered yeast.
Based in Menlo Park, California, Antheia is a synthetic biology company founded in 2015 by Dr. Christina Smolke and Dr. Kristy Hawkins out of Stanford University. The platform engineers yeast cells using large-scale fermentation to convert sugars into complex pharmaceutical molecules, replacing traditional agricultural supply chains with a pipeline of over 70 plant-inspired active pharmaceutical ingredients. Operating as a business-to-business supplier for global drug manufacturers, the enterprise has established strategic commercial partnerships with industry entities such as TAPI and Olon Group. Antheia recently achieved its first commercial delivery of thebaine, a critical ingredient for essential medicines like Narcan, following successful 116,000-liter commercial-scale fermentation runs. To support commercialization and United States manufacturing, the company secured over $175 million in recent equity financing from prominent venture capital firms including Viking Global Investors and Lumira Ventures.
Antheia has raised $162.0M across 4 funding rounds.
Antheia has raised $162.0M in total across 4 funding rounds.
Antheia has raised $162.0M across 4 funding rounds. Most recently, it raised $9.0M Grant in March 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 4, 2026 | $9M Grant | U.S. Department OF Health And Human Services | — | Announced |
| Jan 27, 2026 | $24M Series C Plus | Jeff Karras, Athos | Global Health Investment Corporation | Announced |
| Jun 3, 2025 | $56M Series C | Paul NG, CFA, Joseph LEE | Athos, Civilization Ventures, Federov, IN Q TEL, S Cubed Capital, Sherpalo Ventures, Viking Global Investors | Announced |
| Jul 1, 2021 | $73M Series B | Viking Global Investors | Hillspire, Sherpalo Ventures | Announced |
Antheia has raised $162.0M in total across 4 funding rounds.
Antheia's investors include U.S. Department of Health and Human Services, Jeff Karras, ATHOS, Global Health Investment Corporation, Paul Ng, CFA, Joseph Lee, Civilization Ventures, Federov, In-Q-Tel, S-Cubed Capital, Sherpalo Ventures, Viking Global Investors.